Clinical and experimental evidence demonstrates that perturbations in the growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis are responsible for many important complications seen in CKD, such as growth retardation and protein energy wasting, as well as disease progression [1, 3, 4]. The gene discussed is IGF1; the disease is chronic kidney disease.